Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx “MedGuides” Will Meet 2006 Deadline For FDA Goals, First DataBank Says

Executive Summary

First DataBank's consumer medical information leaflets are fully up-to-date with all black box warnings required by FDA, First DataBank Chief Operating Officer James Wilson declared during the National Association of Chain Drug Stores Pharmacy & Technology conference Aug. 25 in Philadelphia

You may also be interested in...



Mail Order Patient Leaflets Represent “Best Practices,” PCMA Tells FDA

Prescription drug leaflets distributed by mail-order pharmacies are of higher quality than the average retail leaflet, the Pharmaceutical Care Management Association maintains in comments submitted to FDA

Patient Rx Info Coalition Will Develop Prototype Consumer Drug Leaflets

The private-sector Consumer Medicine Information Coalition plans to develop prototypes for written patient prescription information by therapeutic class

“MedGuide” Regulation Advocates Urge FDA To Take First Steps

FDA and pharmacy groups should develop a priority list for mandatory medication guides as a first step towards regulation of consumer information leaflets for all prescriptions, advocates of a regulatory approach to "MedGuides" told an FDA public workshop July 31

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel